The vitamin D receptor in cancer

The Proceedings of the Nutrition Society
James L Thorne, Moray J Campbell

Abstract

Over the last 25 years roles have been established for vitamin D receptor (VDR) in influencing cell proliferation and differentiation. For example, murine knock-out approaches have revealed a role for the VDR in controlling mammary gland growth and function. These actions appear widespread, as the enzymes responsible for 1alpha,25-dihydroxycholecalciferol generation and degradation, and the VDR itself, are all functionally present in a wide range of epithelial and haematopoietic cell types. These findings, combined with epidemiological and functional data, support the concept that local, autocrine and paracrine VDR signalling exerts control over cell-fate decisions in multiple cell types. Furthermore, the recent identification of bile acid lithocholic acid as a VDR ligand underscores the environmental sensing role for the VDR. In vitro and in vivo dissection of VDR signalling in cancers (e.g. breast, prostate and colon) supports a role for targeting the VDR in either chemoprevention or chemotherapy settings. As with other potential therapeutics, it has become clear that cancer cells display de novo and acquired genetic and epigenetic mechanisms of resistance to these actions. Consequently, a range of experimental and clinical o...Continue Reading

References

Apr 1, 1987·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E M Costa, D Feldman
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·E AbeT Suda
Oct 15, 1981·Biochemical and Biophysical Research Communications·C MiyauraT Suda
Sep 1, 1980·International Journal of Epidemiology·C F Garland, F C Garland
Apr 1, 1994·Experimental Cell Research·M GörlachG Dreyfuss
Aug 1, 1994·Cancer·N YamamotoE Sato
Jan 20, 1994·Nature·N A MorrisonJ A Eisman
Aug 1, 1997·Molecular Carcinogenesis·C W MillerH P Koeffler
Mar 6, 1998·Cellular and Molecular Life Sciences : CMLS·B M Turner
Nov 17, 1998·The Journal of Urology·A M De MarzoD S Coffey
Jan 23, 1999·The Journal of Biological Chemistry·S H Hong, M L Privalsky
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·J E CurranL R Griffiths
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 19, 2000·Cancer Causes & Control : CCC·S A InglesG A Coetzee
Jul 6, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P PollyC Carlberg
Nov 15, 2000·Cancer Causes & Control : CCC·M H AhonenP Tuohimaa
Feb 7, 2001·The Journal of Clinical Endocrinology and Metabolism·D ZehnderM Hewison
Mar 10, 2001·Nature·P A FutrealM R Stratton
May 10, 2001·The Journal of Clinical Endocrinology and Metabolism·D TiosanoZ Hochberg

❮ Previous
Next ❯

Citations

Aug 24, 2011·Reviews in Endocrine & Metabolic Disorders·Stephen W ByersYong-Sik Bong
Jun 30, 2010·Journal of Gastrointestinal Cancer·David J HughesPavel Vodicka
Nov 13, 2012·Cancer Letters·Rajendra G MehtaRajeshwari Mehta
Mar 10, 2011·The Proceedings of the Nutrition Society·Elizabeth K LundIan T Johnson
Feb 26, 2011·Omics : a Journal of Integrative Biology·Paola MutiSabrina Strano
Apr 30, 2009·Annual Review of Nutrition·Marjorie L McCulloughTinisha L Mayo
Sep 23, 2010·Cancer Prevention Research·Wei YuLeena Hilakivi-Clarke
Apr 8, 2014·Nature Reviews. Cancer·David FeldmanBrian J Feldman
Apr 29, 2014·Archives of Dermatological Research·Xian-Zhi ZhaoZhi-Yong Yuan
Oct 23, 2014·Journal of Cellular Physiology·Mark D LongMoray J Campbell
May 9, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Sarita JenaPaul D Thompson
Jun 15, 2011·Molecular and Cellular Endocrinology·Srilatha SwamiDavid Feldman
May 21, 2016·Nuclear Receptor Research·Mark D Long, Moray J Campbell
Mar 10, 2009·Progress in Biophysics and Molecular Biology·William B GrantArmin Zittermann
Oct 3, 2015·The Journal of Steroid Biochemistry and Molecular Biology·Craig L DoigMoray J Campbell
Sep 22, 2012·Mass Spectrometry Reviews·Rose M GathunguPaul Vouros
Dec 17, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Prashant K SinghMoray J Campbell
Mar 26, 2014·Experimental Hematology & Oncology·Christian S RogersPaul B Tchounwou
Oct 28, 2015·Journal of Immunology Research·Randa RedaDoaa Zakaria
Oct 27, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Prashant K SinghMoray J Campbell
Oct 13, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Wei-Lin Winnie WangMartin Tenniswood
Dec 17, 2014·Oncology Reports·Anna A BrożynaAndrzej T Slominski
May 27, 2014·Frontiers in Physiology·Wei-Lin W Wang, Martin Tenniswood
Feb 22, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Ni ZengFlorian Lang
May 1, 2009·Carcinogenesis·Sara RaimondiSara Gandini
Sep 6, 2011·Human Molecular Genetics·Fábio PereiraMaría Jesús Larriba
Jan 20, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Nasim JamaliNader Sheibani
Sep 26, 2017·Genetic Epidemiology·Britney E GrahamScott M Williams
Oct 13, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haidan M El-ShorbagySalwa Sabet
Aug 6, 2011·European Journal of Gastroenterology & Hepatology·David J HughesMaria O'sullivan
Sep 27, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ying HuYu-Jui Yvonne Wan
Mar 1, 2012·Current Colorectal Cancer Reports·Rong LuJun Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Alfredo BerrutiLuigi Dogliotti
Trends in Endocrinology and Metabolism : TEM
Tai C Chen, Michael F Holick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Whitney Banach-PetroskyCory Abate-Shen
© 2022 Meta ULC. All rights reserved